These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38057118)

  • 1. Fondaparinux Results in Similar Pregnancy Outcomes with Lower Adverse Reaction Rates Compared to Low Molecular Weight Heparin in Chinese Recurrent Miscarriage Women.
    Liu C; Ma C; Hao Y
    Tohoku J Exp Med; 2024 Mar; 262(2):125-131. PubMed ID: 38057118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcomes and adverse events in patients with recurrent miscarriage receiving fondaparinux versus low molecular-weight heparin: A meta-analysis.
    Mu F; Wang M; Huang J; Wang F
    Eur J Obstet Gynecol Reprod Biol; 2023 Aug; 287():29-35. PubMed ID: 37276726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion.
    Zhao L; Bi S; Fu J; Qi L; Li L; Fu Y
    Front Endocrinol (Lausanne); 2021; 12():717630. PubMed ID: 34721290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
    de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
    Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
    Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effect of low molecular weight heparin in unexplained recurrent pregnancy loss: a meta-analysis of randomized controlled trials.
    Wang G; Zhang R; Li C; Chen A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7601-7608. PubMed ID: 34311655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Effects of Low-Molecular-Weight Heparin and Fondaparinux on Liver Function in Patients With Pulmonary Embolism.
    Yang X; Li N; Guo T; Guan X; Tan J; Gao X; Wu Y; Jia L; Gu M; Hua L; Liu H
    J Clin Pharmacol; 2020 Dec; 60(12):1671-1678. PubMed ID: 32639644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.
    Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH
    J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis.
    Potdar N; Gelbaya TA; Konje JC; Nardo LG
    Hum Reprod Update; 2013; 19(6):674-84. PubMed ID: 23912476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Molecular-Weight Heparin for the Treatment of Unexplained Recurrent Miscarriage With Negative Antiphospholipid Antibodies: A Randomized Controlled Trial.
    Shaaban OM; Abbas AM; Zahran KM; Fathalla MM; Anan MA; Salman SA
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):567-572. PubMed ID: 27572887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
    Mutlu I; Mutlu MF; Biri A; Bulut B; Erdem M; Erdem A
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):267-73. PubMed ID: 25268607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: A meta-analysis of randomized controlled trial.
    Yan X; Wang D; Yan P; Li H
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():22-30. PubMed ID: 34794071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
    Areia AL; Fonseca E; Areia M; Moura P
    Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of low molecular weight heparin on recurrent pregnancy loss: A systematic review and meta-analysis.
    Jiang F; Hu X; Jiang K; Pi H; He Q; Chen X
    Taiwan J Obstet Gynecol; 2021 Jan; 60(1):1-8. PubMed ID: 33494980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis.
    Yang Z; Shen X; Zhou C; Wang M; Liu Y; Zhou L
    Lupus; 2021 Jan; 30(1):70-79. PubMed ID: 33081590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
    Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
    Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial.
    Quenby S; Booth K; Hiller L; Coomarasamy A; de Jong PG; Hamulyák EN; Scheres LJ; van Haaps TF; Ewington L; Tewary S; Goddijn M; Middeldorp S; ;
    Lancet; 2023 Jul; 402(10395):54-61. PubMed ID: 37271152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.
    Szummer K; Oldgren J; Lindhagen L; Carrero JJ; Evans M; Spaak J; Edfors R; Jacobson SH; Andell P; Wallentin L; Jernberg T
    JAMA; 2015 Feb; 313(7):707-16. PubMed ID: 25688782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.